pharma.markets

  • HOME
  • Imprint

Vaccines

Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

25/02/2021 MaP 0

The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that […]

Copyright European Commission 2021

EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

20/02/2021 MaP 0

The European Union has announced today an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is […]

In Vitro Study Published in The New England Journal of Medicine

17/02/2021 MaP 0

Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations Pfizer Inc. (NYSE: PFE) and BioNTech SE […]

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

17/02/2021 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses […]

efe

A test that detects covid antibodies with 98% sensitivity has been developed in Valencia

15/02/2021 MaP 0

It exceeds the sensitivity of other tests on the market. A super-sensitive test to detect coronavirus antibodies has been developed in Valencia The Technological Institute […]

Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

12/02/2021 MaP 0

U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people Pfizer Inc. (NYSE: PFE) and BioNTech SE […]

Pfizer and BioNTech Publish Data from In Vitro Studies

08/02/2021 MaP 0

….in Nature Medicine Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants Pfizer Inc. (NYSE: PFE) […]

Valencia Comunidad doses vaccines to March 2021 –

07/02/2021 MaP 0

After the today (6.2.2021), Ximo Puig said that from next Monday until 31 March, the Valencian Community has already guaranteed the receipt of at least, […]

Merck and BioNTech Extend Strategic Partnership Through Accelerated Supply of Urgently Needed Lipids

05/02/2021 MaP 0

Merck, in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and increase the amount of lipid delivery towards the end […]

pharma.markets bygigis.com

Covid19 Vaccine Europe stats 2.2.2021

04/02/2021 MaP 0

EU boosts humanitarian aid budget for 2021 as needs rise

26/01/2021 MaP 0

As global humanitarian needs worsen further due to the consequences of the coronavirus pandemic and the effects of climate change, the European Commission has adopted […]

EIB provides €20 million to support RDI activities and growth at Galenicum

26/01/2021 MaP 0

The European Investment Bank (EIB) will provide €20 million to finance the research, development and innovation (RDI) programme of Galenicum, a pharmaceutical company founded in […]

Posts navigation

1 2 … 5 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  • EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries
  • In Vitro Study Published in The New England Journal of Medicine
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Archive

  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

    25/02/2021 0
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

    25/02/2021 0
  • Copyright European Commission 2021

    EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

    20/02/2021 0
  • In Vitro Study Published in The New England Journal of Medicine

    17/02/2021 0
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

    17/02/2021 0
Archives
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes